July 17 (Reuters) - GSK will halt development of its experimental drug to treat refractory chronic cough after the therapy ...
Shares in GSK fell sharply on Friday after the pharma titan announced it was stopping the development of a refractory chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results